StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Elite Pharmaceuticals's pe ratio was 5.0× on Oct 19, 2026, against 44.3× a year earlier. Over the last 5 years it ranged from 4.0× to 53.2×, with a median of 9.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20265.0×−44.0
2025Dec 31, 202549.0×+4.7
2024Oct 31, 202444.3×+30.3
2023Dec 29, 202314.0×+9.3
2022Dec 30, 20224.7×−0.7
2021Dec 31, 20215.3×−13.8
2020Dec 31, 202019.2×−94.4
2017Oct 31, 2017113.5×+29.9
2016Dec 30, 201683.6×+15.8
2015Dec 31, 201567.8×+1.6
2014Jan 31, 201466.1×+39.7
2013Dec 31, 201326.5×+20.4
2012Oct 31, 20126.0×–

More Elite Pharmaceuticals figures

See a number that looks wrong?